Bone Mineral Changes in Epilepsy Patients During Initial Years of Antiepileptic Drug Therapy
Antiepileptic drug (AED) therapy is associated with decreased bone mineral density; however, the time course for this development is unclear. The aim of this study was to evaluate bone mineral changes during the initial years of AED therapy in AED-naive, newly diagnosed epilepsy patients compared wi...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/43913 |
| _version_ | 1848756845535035392 |
|---|---|
| author | Shiek Ahmad, B. O'Brien, T. Gorelik, A. Hill, Keith Wark, J. |
| author_facet | Shiek Ahmad, B. O'Brien, T. Gorelik, A. Hill, Keith Wark, J. |
| author_sort | Shiek Ahmad, B. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Antiepileptic drug (AED) therapy is associated with decreased bone mineral density; however, the time course for this development is unclear. The aim of this study was to evaluate bone mineral changes during the initial years of AED therapy in AED-naive, newly diagnosed epilepsy patients compared with non-AED users. In 49 epilepsy patients newly started on AEDs and in 53 non-AED users of both genders, bone mineral density (BMD) and bone mineral content were measured using dual-energy X-ray absorptiometry at baseline (within the first year of therapy) and at least 1 yr later. Bone changes between the 2 assessments, adjusted for age, height, and weight, were calculated as the annual rate of change. The median duration of AED therapy was 3.5 mo at baseline and 27.6 mo at follow-up. No overall difference was found in mean BMD and bone mineral content measures between user and nonuser cohorts in both cross-sectional baseline and the annual rate of change (p > 0.05). However, users on carbamazepine monotherapy (n = 11) had an increased annual rate of total hip (−2.1% vs −0.8%, p = 0.020) and femoral neck BMD loss (−2.1% vs −0.6%, p = 0.032) compared to nonusers. They also had a marginally higher rate of femoral neck BMD loss (−2.1%, p = 0.049) compared with valproate (−0.1%, n = 13) and levetiracetam users (+0.6%, n = 13). During the initial years of AED treatment for epilepsy, no difference was found in bone measures between AED users as a group and nonuser cohorts.However, the data suggested that carbamazepine monotherapy was associated with increased bone loss at the hip regions, compared to users of levetiracetam or valproate and nonusers. Larger studies of longer duration are warranted to better delineate the bone effects of specific AEDs, with further consideration of the role of early dual-energy X-ray absorptiometry scanning and careful AED selection in potentially minimizing the impact on bone health in these patients. |
| first_indexed | 2025-11-14T09:18:40Z |
| format | Journal Article |
| id | curtin-20.500.11937-43913 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T09:18:40Z |
| publishDate | 2016 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-439132017-09-13T13:42:27Z Bone Mineral Changes in Epilepsy Patients During Initial Years of Antiepileptic Drug Therapy Shiek Ahmad, B. O'Brien, T. Gorelik, A. Hill, Keith Wark, J. Antiepileptic drug (AED) therapy is associated with decreased bone mineral density; however, the time course for this development is unclear. The aim of this study was to evaluate bone mineral changes during the initial years of AED therapy in AED-naive, newly diagnosed epilepsy patients compared with non-AED users. In 49 epilepsy patients newly started on AEDs and in 53 non-AED users of both genders, bone mineral density (BMD) and bone mineral content were measured using dual-energy X-ray absorptiometry at baseline (within the first year of therapy) and at least 1 yr later. Bone changes between the 2 assessments, adjusted for age, height, and weight, were calculated as the annual rate of change. The median duration of AED therapy was 3.5 mo at baseline and 27.6 mo at follow-up. No overall difference was found in mean BMD and bone mineral content measures between user and nonuser cohorts in both cross-sectional baseline and the annual rate of change (p > 0.05). However, users on carbamazepine monotherapy (n = 11) had an increased annual rate of total hip (−2.1% vs −0.8%, p = 0.020) and femoral neck BMD loss (−2.1% vs −0.6%, p = 0.032) compared to nonusers. They also had a marginally higher rate of femoral neck BMD loss (−2.1%, p = 0.049) compared with valproate (−0.1%, n = 13) and levetiracetam users (+0.6%, n = 13). During the initial years of AED treatment for epilepsy, no difference was found in bone measures between AED users as a group and nonuser cohorts.However, the data suggested that carbamazepine monotherapy was associated with increased bone loss at the hip regions, compared to users of levetiracetam or valproate and nonusers. Larger studies of longer duration are warranted to better delineate the bone effects of specific AEDs, with further consideration of the role of early dual-energy X-ray absorptiometry scanning and careful AED selection in potentially minimizing the impact on bone health in these patients. 2016 Journal Article http://hdl.handle.net/20.500.11937/43913 10.1016/j.jocd.2016.07.008 restricted |
| spellingShingle | Shiek Ahmad, B. O'Brien, T. Gorelik, A. Hill, Keith Wark, J. Bone Mineral Changes in Epilepsy Patients During Initial Years of Antiepileptic Drug Therapy |
| title | Bone Mineral Changes in Epilepsy Patients During Initial Years of Antiepileptic Drug Therapy |
| title_full | Bone Mineral Changes in Epilepsy Patients During Initial Years of Antiepileptic Drug Therapy |
| title_fullStr | Bone Mineral Changes in Epilepsy Patients During Initial Years of Antiepileptic Drug Therapy |
| title_full_unstemmed | Bone Mineral Changes in Epilepsy Patients During Initial Years of Antiepileptic Drug Therapy |
| title_short | Bone Mineral Changes in Epilepsy Patients During Initial Years of Antiepileptic Drug Therapy |
| title_sort | bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy |
| url | http://hdl.handle.net/20.500.11937/43913 |